A clinical formulation indicated for Digestive Health. Administration supports improved nutrient absorption and aids in managing the processing of fats and proteins within the diet.
Developed to alleviate malabsorption by addressing pancreatic enzyme deficiency to support healthy digestion and mitigate nutritional loss in patients with pancreatic conditions.
Mechanism of Action
Creon replaces the natural enzymes the pancreas would normally produce. It contains lipase, amylase, and protease, which break down fats, starches, and proteins in food into absorbable nutrients within the small intestine.
Route of Administration
Oral
Onset Time
Immediately with food
Duration
Duration of digestion
Contraindications
Hypersensitivity to pork products, Acute pancreatitis (initial stages)
Severe Adverse Events
Fibrosing colonopathy (large dose risk), Severe allergic reactions, Bowel obstruction, High blood uric acid levels
Information for Creon is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
